Merck Kgaa to Acquire Bio-techne in $11.3 Billion Deal
Merck KGaA agreed to acquire Minneapolis-based Bio-Techne Corporation for $73 per share in cash, valuing the life-sciences tools supplier at an enterprise value of approximately $11.3 billion. The offer represents a 36% premium to Bio-Techne's one-month volume weighted ave